UR-2922 is an integrin antagonist that selectively targets the GPIIb/IIIa receptor on platelets. This compound exhibits potent antiplatelet aggregation activity, making it a useful tool for research into cardiovascular diseases. With its high affinity for human platelet receptors and favorable pharmacokinetic properties, UR-2922 is ideal for studies aimed at understanding and inhibiting cardiovascular pathophysiology.
UR-2922 is an integrin antagonist that selectively targets the GPIIb/IIIa receptor on platelets. This compound exhibits potent antiplatelet aggregation activity, making it a useful tool for research into cardiovascular diseases. With its high affinity for human platelet receptors and favorable pharmacokinetic properties, UR-2922 is ideal for studies aimed at understanding and inhibiting cardiovascular pathophysiology.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
